Morgan Stanley Hires Cohen From Truist

Morgan Stanley has hired veteran investment banker Daniel Cohen from Truist Financial Corp. where he was the head of the firm’s healthcare services advisory business. In his new role, Cohen will focus on dealmaking in the pharmaceutical services sector.

Morgan Stanley declined to comment. A Truist spokesperson did not respond immediately to a request for comment and Cohen didn’t reply to a message sent to him via LinkedIn.

Cohen’s hire comes after veteran pharmaceutical industry bankers Arek Kurkciyan and Dennis Crandall left Morgan Stanley last year to join Moelis & Co.

Cohen spent over one year at Truist and served as the head of pharmaceutical services investment banking and healthcare sponsor coverage before being promoted to the head of the healthcare services unit as per his LinkedIn profile.

Earlier he served as the global head of healthcare services investment banking at RBC Capital Markets, with prior investment banking roles at Oppenheimer Holdings Inc and JP Morgan Chase & Co. as per his profile.

Cohen took a break from investment banking in 2010 when he joined the Life Sciences firm Catalent Inc. in a business development role. Morgan Stanley’s global M&A franchise is currently being led by John Collins who previously served as global head of healthcare investment banking at the bank.

In America, sole leadership of Morgan Stanley’s M&A franchise is being passed on to Tom Miles, co-head of business with Brian Healy. Healy announced plans to retire in August according to an internal memo sent to employees in June.

For more updates regarding trade finance all across the globe, check our news updates!

Originally published at https://www.emeriobanque.com.